Cargando…
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.
The chemistry of the mitomycin C-related drug indoloquinone EO9 would suggest that its mechanism of action is likely to involve DNA damage after reductive activation. The ability of this agent to induce DNA damage in intact cells has been examined using alkaline filter elution. After treatment with...
Autores principales: | Bailey, S. M., Wyatt, M. D., Friedlos, F., Hartley, J. A., Knox, R. J., Lewis, A. D., Workman, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228210/ https://www.ncbi.nlm.nih.gov/pubmed/9413948 |
Ejemplares similares
-
DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?
por: Workman, P., et al.
Publicado: (1989) -
DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
por: Plumb, J. A., et al.
Publicado: (1994) -
DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?
por: Smitskamp-Wilms, E., et al.
Publicado: (1995) -
EO9: relationship between DT-diaphorase levels and response in vitro and in vivo.
por: Collard, J., et al.
Publicado: (1995) -
Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents.
por: Doherty, G. P., et al.
Publicado: (1998)